Whereas the oncogenicity of NTRK1 fusions was well characterized in papillary thyroid carcinoma [25] and lung adenocarcinoma [21], it remains to be elucidated in colon cancer. This evidence concerns the gene NTRK1 and malignant colon neoplasm.